
Anne Chiang, MD, PhD, discusses the management of immune-related adverse effects in lung cancer.

Anne Chiang, MD, PhD, is an associate professor of medicine in the Section of Medical Oncology and the associate cancer center director of Clinical Initiatives at the Yale School of Medicine

Anne Chiang, MD, PhD, discusses the management of immune-related adverse effects in lung cancer.

A new FDA program is giving patients and providers first-time access to patient-reported outcome data from cancer clinical trials of marketed treatments.

Consolidation of community oncology practices with hospital-based cancer centers is an accelerating trend that will affect future healthcare delivery models. This year, the Community Oncology Alliance reported hospital acquisitions and corporate mergers among 55% of 1338 community oncology practices surveyed, representing a 20% increase over the previous year's results.